F Guerrero-Romero1, M Rodríguez-Morán. 1. Medical Research Unit in Clinical Epidemiology, of the Mexican Social Security Institute, Mexico. guerrero@omanet.com.mx
Abstract
OBJECTIVE: To determine whether impaired glucose tolerance (IGT) is predicted by high Fasting Insulin-to-Glucose (FIG) ratio and to establish its correlation with insulin resistance and fasting insulin. MATERIAL AND METHODS: A population-based three-year follow-up study was performed. The target population consisted of healthy volunteers, men and non-pregnant women aged 30 years or over. Participants were required to have normal referenced ranges of OGTT and blood pressure. Previous diagnosis of chronic diseases was an exclusion criterion. At baseline and at the 3-yr of follow-up, an OGTT was performed. The ratio of serum Fasting Insulin (microUI/ml)/Fasting Glucose (mg/dl) was used to calculate the FIG ratio. Insulin action and secretion were estimated by HOMA and Insulinogenic index, respectively. RESULTS: The FIG ratio was directly correlated with the HOMA index (r=0.83, p<0.01) and fasting insulin (r=0.95, p<0.001). Multivariate logistic regression analysis showed that IGT was more likely to develop in subjects with high FIG ratio (RR 5.01; CI(95%) 1.9-12.2, p=0.02), high HOMA index (RR 6.1; CI(95%) 2.1-11.1, p=0.01), and fasting hyperinsulinemia (RR 4.7 CI(95%) 2.7-13.2, p<0.05). The cutoff point of FIG ratio for determining the risk of developing IGT was 0.25 +/- 0.05. CONCLUSIONS: The FIG ratio could be a reliable alternative for the screening of apparently healthy subjects in high risk groups.
OBJECTIVE: To determine whether impaired glucose tolerance (IGT) is predicted by high Fasting Insulin-to-Glucose (FIG) ratio and to establish its correlation with insulin resistance and fasting insulin. MATERIAL AND METHODS: A population-based three-year follow-up study was performed. The target population consisted of healthy volunteers, men and non-pregnant women aged 30 years or over. Participants were required to have normal referenced ranges of OGTT and blood pressure. Previous diagnosis of chronic diseases was an exclusion criterion. At baseline and at the 3-yr of follow-up, an OGTT was performed. The ratio of serum Fasting Insulin (microUI/ml)/Fasting Glucose (mg/dl) was used to calculate the FIG ratio. Insulin action and secretion were estimated by HOMA and Insulinogenic index, respectively. RESULTS: The FIG ratio was directly correlated with the HOMA index (r=0.83, p<0.01) and fasting insulin (r=0.95, p<0.001). Multivariate logistic regression analysis showed that IGT was more likely to develop in subjects with high FIG ratio (RR 5.01; CI(95%) 1.9-12.2, p=0.02), high HOMA index (RR 6.1; CI(95%) 2.1-11.1, p=0.01), and fasting hyperinsulinemia (RR 4.7 CI(95%) 2.7-13.2, p<0.05). The cutoff point of FIG ratio for determining the risk of developing IGT was 0.25 +/- 0.05. CONCLUSIONS: The FIG ratio could be a reliable alternative for the screening of apparently healthy subjects in high risk groups.
Authors: Jennifer H Stern; Gordon I Smith; Shiuwei Chen; Roger H Unger; Samuel Klein; Philipp E Scherer Journal: J Endocrinol Date: 2019-11 Impact factor: 4.286
Authors: Juris J Meier; Bjoern A Menge; Thomas G K Breuer; Christophe A Müller; Andrea Tannapfel; Waldemar Uhl; Wolfgang E Schmidt; Henning Schrader Journal: Diabetes Date: 2009-06-09 Impact factor: 9.461
Authors: Samuel Dagogo-Jack; Nkiru Umekwe; Amy A Brewer; Ibiye Owei; Vamsee Mupparaju; Renate Rosenthal; Jim Wan Journal: BMJ Open Diabetes Res Care Date: 2022-03